CD274 and neoplasm: Overexpression of these miRNAs in the tumor microenvironment might enhance immunogenicity and improve the outcome of ICI therapies, not only in advanced cases but also in cisplatin ineligible, in primary or recurrent NMIBC where high level of TERT and PD-L1 can be detected.